The expression of an R3 lipopolysaccharide-core by pathotypes of Escherichia coli

J Appl Microbiol. 2004;96(5):982-6. doi: 10.1111/j.1365-2672.2004.02233.x.

Abstract

Aims: To investigate the incidence of an R3 lipopolysaccharide (LPS)-core amplicon in a range of pathotypes of Escherichia coli, including Verocytotoxin-producing E. coli (VTEC), enteroaggregative E. coli (EAggEC) and enteropathogenic E. coli (EPEC).

Methods and results: A total of 100 strains of E. coli belonging to a range of pathotypes, including 41 strains of VTEC, were screened for the genes encoding the R3 LPS-core using PCR. Fifty-four per cent produced an amplicon with the R3 primer set. Of the 41 VTEC, 66% had an R3 LPS-core with a PCR product being observed with all strains belonging to serotypes O26:H11, O111ac:H- and O145:H25. However, 46% of enteroaggregative E. coli and 50% of enteropathogenic E. coli were also shown to have an R3 LPS-core structure.

Conclusions: Strains with an R3 LPS-core are widely distributed within the species E. coli.

Significance and impact of the study: Strains of E. coli with an R3 LPS-core structure appear not to be associated with a specific pathotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Escherichia coli / genetics*
  • Escherichia coli O157 / genetics
  • Genes, Bacterial / genetics
  • Humans
  • Lipopolysaccharides / analysis*
  • Nucleic Acid Amplification Techniques / methods
  • Polymerase Chain Reaction
  • Serotyping
  • Shiga Toxins / biosynthesis

Substances

  • Lipopolysaccharides
  • Shiga Toxins